HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Pharmavite Monthly Survey Shows Supplement Use In US Continues Growing During Pandemic

Nature Made Marketer Provides More Than 7M Immune Support Products To Teachers

Executive Summary

Teachers are among the 500 to 700 consumers responding to monthly nationwide survey on nutritional supplement usage Pharmavite started in April 2020 as novel coronavirus pandemic began widespread impact across US, says chief marketing officer Rhonda Hoffman.

You may also be interested in...



Gummy Format And Immunity Health Have Legs As Sales Drivers For US Supplement Market

“It's not that gummies have taken over the entire pill format,” says nutritional product business consultant Thomas Aarps. “But the trend is obviously to gummies.” Meanwhile, multiple COVID variants keep consumers attuned to immunity health. “Immunity is big, it's going to be big.”

Is More Always Better? Vous Vitamin CEO Says Personalized Product Sales Grow On Fewer Doses

Brad Helfand says direct-to-consumer personalized vitamins firm is seeing “strong and growing demand for our personalized all-in-one multivitamin products,” indicating a trend of consumer interest in similar products. 

In $4.4 Trillion ‘Global Wellness Economy’ Of 2020, Supplement Sales Accounted For $137.7 Billion

Global Wellness Institute’s vitamins and supplements, healthy-labeled foods and beverages and weight loss products and services overall showed 3.6% sales growth to $945bn from 2019 to 2020, according to institute’s latest report.

Related Content

Topics

Latest News
See All
UsernamePublicRestriction

Register

RS151854

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel